In a new interview with Vulture, Sufjan Stevens opened up about his health following his 2023 diagnosis with Guillain-Barré ...

The oral presentation highlighted the benefits of tanruprubart in improving patient outcomes compared to current standard treatments for Guillain-Barré Syndrome (GBS), which lacks FDA-approved ...

The Task Force of the European Academy of Neurology and the Peripheral Nerve Society published updated guidelines in 2024 on the diagnosis and treatment of Guillain-Barré syndrome (GBS), which ...

Two days and a battery of tests later, Bergstrom underwent a lumbar puncture and was diagnosed with Guillain-Barré Syndrome, a rare condition in which the body’s immune system attacks the ...

The company’s lead investigational therapy, tanruprubart, demonstrated significant benefits over current standard care for Guillain-Barré Syndrome (GBS), a rare autoimmune disorder. At the ...

The singer-songwriter, 49, opened up about his health following his 2023 diagnosis with Guillain-Barré syndrome in an interview with Vulture published on Wednesday, May 14. "I’m okay.

Sufjan Stevens gave a rare health update following his 2023 diagnosis with Guillain-Barré syndrome "I’m okay. Situation normal, all up, kind of a thing," Stevens said in an interview with Vulture ...

Barre syndrome is definitely one of the less common. This condition, which affects the body's nerves and causes muscle ...

Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), will present data from its 15-HMedIdeS-09 Phase 2 single arm study of imlifidase, a first in class IgG cleaving enzyme, in Guillain-Barré Syndrome ...

To tell it to a 20-year-old Ryan Warsofky, a defenseman from Sacred Heart University relegated to exactly zero games as a ...